Tag Archives: Javlor
Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
Docetaxel(Taxotere) has long been considered the standard of care for second-line treatment of advanced NSCLC. However, the disadvantage of using this agent include the need to administer it with corticosteroid premedication and its toxicity profile A new study published in … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer
Tagged docetaxel, Javlor, Non small cell lung cancer, NSCLC, Survival, Taxotere, Treatment, vinflunine
Comments Off on Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)